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ABSTRACT 
 
 The pathologic development of heterotopic ossification (HO) is well described in 
patients with extensive trauma or with hyperactivating mutations of the bone 
morphogenetic protein (BMP) receptor ACVR1. However, identification of progenitor 
cells contributing to this process remains elusive. Here we show that connective tissue 
cells contribute to a substantial amount of HO anlagen caused by trauma using post-natal, 
tamoxifen-inducible, scleraxis-lineage restricted reporter mice (Scx-
creERT2/tdTomato
fl/fl
). When the scleraxis-lineage is restricted specifically to adults prior 
to injury marked cells contribute to each stage of the developing HO anlagen and co-
express markers of endochondral ossification (Osterix, SOX9). Furthermore, these adult 
pre-injury restricted cells co-expressed mesenchymal stem cell markers including 
PDGFRα, Sca1, and S100A4 in HO. When constitutively active ACVR1 (caACVR1) was 
expressed in scx-cre cells in the absence of injury (Scx-cre/caACVR1
fl/fl
), tendons and 
joints formed HO. Post-natal lineage-restricted, tamoxifen-inducible caACVR1 
expression (Scx-creERT2/caACVR1
fl/fl
) was sufficient to form HO after directed 
cardiotoxin-induced muscle injury. These findings suggest that cells expressing scleraxis 
within muscle or tendon contribute to HO in the setting of both trauma or hyperactive 
bone morphogenetic protein receptor (e.g. caACVR1) activity.  
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INTRODUCTION 
 
Heterotopic ossification (HO) is a pathologic process in which ectopic bone forms 
within muscle, tendons, or other soft tissues. Clinically, HO lesions develop at sites of 
musculoskeletal injury or burns, and in patients with hyperactive BMP receptor signaling 
(Shore et al., 2006). Because HO forms in several tissue types, identification of common 
progenitors has been an area of growing interest. 
Several different progenitor cells have been evaluated in the context of BMP-
induced HO models within muscle. Using lineage-tracing mice, Tie2+ cells have been 
noted to undergo osteogenic differentiation in vivo (Lounev et al., 2009; Medici et al., 
2010). These Tie2+ cells have been shown to be muscle-resident CD31-/CD45-
/PDGFRα+/Sca1+ cells suggesting they are mesenchymal stem cells and not endothelial 
cells as initially thought (Wosczyna et al., 2012). The contribution of Glast-cre cells that 
reside within the muscle interstitium has also been evaluated. These cells co-express 
mesenchymal markers including PDGFRα and S100A4, and also appear to contribute to 
different stages of HO (Kan et al., 2013). In these models, however, BMP activity is not 
limited to the contributing MSCs, and it is not clear whether BMP is required to engender 
a niche supportive of ectopic bone.  
Clinically, HO is often observed in close proximity to connective tissue within 
myofascial planes and joints. Additionally, transection of the Achilles’ tendon in murine 
models leads to robust ectopic bone through endochondral ossification. Scleraxis, a basic 
helix-loop-helix (bHLH) transcription factor, is expressed in connective tissues including 
tendon, ligaments, and perimysium between muscle fibers (Blitz et al., 2013; Dyment et 
al., 2014; Schweitzer et al., 2001; Sugimoto et al., 2013). Furthermore, scleraxis-
expressing cells collected after tendon injury exhibit robust chondrogenic potential both 
in vitro and when implanted in vivo (Asai et al., 2014).  
Given the shared presence of scleraxis-expressing cells in both muscle and 
tendon, we hypothesized that these cells contribute to HO formed after trauma or due to 
hyperactive BMP signaling.  
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RESULTS 
 
Scleraxis-lineage cells contribute to all phases of trauma-induced HO (tHO) 
 We first demonstrated that the Achilles tendon, which is transected in the 
burn/tenotomy model of trauma-induced HO (tHO) (Fig S1A), is marked almost 
completely by both Scx-cre lineage cells (Scx-cre/ROSA26
mTmG
) and by active expression 
of Scx (Scx-GFP) prior to injury (Fig 1A; Fig S1B). By comparison, intramuscular 
regions demonstrate a more restrictive pattern with both Scx-cre lineage and active Scx 
expression limited to areas of connective tissue (Fig S2). These regions are the site of 
ectopic bone formation in our second model of HO formation utilizing an intramuscular 
BMP-loaded scaffold (bHO). 
 Using our burn/tenotomy model of tHO, we found that Scx-cre cells contribute to 
a majority of the fibroproliferative (95.1±1.2%) and chondroid (65.8±13.0%) regions of 
developing tHO (Fig 1B, Fig S3). To exclude any contribution of trauma-induced 
activation of scleraxis we then used post-natal, tamoxifen-inducible, scleraxis-lineage 
restricted reporter mice (Scx-creERT2/tdTomato
fl/fl
) with tamoxifen activation ending four 
days prior to injury (Fig 1C; Fig S4). These animals were then evaluated for the 
formation of either tHO or bHO (Fig 1C). We found that Scx-creERT2-labeled cells 
(tdTomato+) contribute to all stages of HO development and could be found in 
fibroproliferative (50.0±25.6 %), chondroid (31.0±7.8%), and endosteal (49.4±18.6) 
regions of tHO (Fig 1D,E).  
 
Scx-creERT2 cells contribute directly endochondral ossification in both tHO and bHO.  
 Given the observed contribution of Scx-creERT2 cells to tHO we wanted to 
identify whether these cells contribute directly to the process of endochondral ossification 
by which HO transitions from cartilage to bone. First we identified areas of tHO in Scx-
creERT2/tdTomato
fl/fl
 mice demonstrating robust endochondral ossification (Fig 2A). 
These tissues are enriched for chondrogenic (SOX9) and osteogenic (OSX) 
differentiation markers (Fig 2B-D). Importantly, tdTomato+ cells in this model expressed 
both SOX9 and OSX in tHO (Fig 2B-D). Similar findings were observed in our BMP-
loaded scaffold model, although bHO was predictably more ossified with comparatively 
diminished markers of active endochondral ossification versus tHO (Fig 2E-H).  
 
Scx-creERT2 cells display a mesenchymal cell phenotype  
Next, we explored the relationship between Scx-creERT2 cells and MSC 
populations which have previously been shown to contribute to HO. Specifically, we 
examined PDGFRα and S100A4, which are expressed by Glast-cre cells (Kan et al., 
2013), and  Sca1 which is expressed by Tie2+ non-endothelial cells (Wosczyna et al., 
2012). In both tHO (Fig 3A-D) and bHO (Fig 3E-H) we noted a high percentage of 
tdTomato+ cells expressing these markers, however, not all MSC marker+ cells were 
tdTomato+ consistent with the heterogeneity of HO. Interestingly, when we evaluated the 
uninjured tissues, while these markers were present, there was no evidence of enrichment 
in either tendinous or muscular bodies (Fig S5). 
 
Expression of caACVR1 within Scx-cre cells results in HO at the joints 
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 To clarify whether Scx-cre cells are capable of producing HO we bred mice with 
Scx-cre lineage-restricted caACVR1 expression (Scx-cre/caACVR1
fl/wt
). Strikingly, Scx-
cre/caACVR1
fl/wt
 mutant mice developed HO at the joints, with 100% of hindlimbs 
showing HO at the Achilles’ tendon, in the absence of traumatic insult (Fig 4A-D), 
though no HO was detectable within muscle (Fig S6). Generation of mutant mice 
conditionally expressing caACVR1 in muscle- or osteoblast-cells (Ckmm-
cre/caACVR1
fl/wt
 and Col1.creERT/caACVR1
fl/wt
) did not form HO suggesting that BMP 
receptor hyperactivity in differentiated muscle or osteoblasts is unable to cause HO (Fig 
S7). 
 
Expression of caACVR1 in Scx-creERT cells results in intramuscular HO after trauma 
 Notably, intramuscular HO lesions in patients with fibrodysplasia ossificans 
progressiva (FOP) form after muscle trauma. Because HO was not observed within the 
muscle of mice with caACVR1 in Scx-cre cells without injury, we investigated the effect 
of injury on caACVR1 expression in these cells. 
 First, to evaluate the effect of intramuscular inflammation on this system we 
utilized a separate method of injury from our tHO and bHO, injection of cardiotoxin 
directly into the muscle body. Using our Scx-GFP reporter we demonstrated that this was 
sufficient to drive an increase in Scx expression in areas adjacent to connective tissue 
(Fig S8). To exclude any contribution of cardiotoxin-induced activation of scleraxis we 
then designed a post-natal, tamoxifen-inducible, scleraxis-lineage restricted model of 
caACVR1 expression (Scx-creERT2/caACVR1
fl/wt
). This system restricted caACVR1 
expression to only tamoxifen activated Scx-creERT2 cells. After tamoxifen washout Scx-
creERT2/caACVR1
fl/wt
 mice received cardiotoxin-induced injury. MicroCT demonstrated 
the presence of ectopic bone within the hamstring 20 days post-cardiotoxin (Fig 4E). 
Routine histology confirmed the presence of heterotopic bone with robust Alcian blue 
and Alizarin red staining (Fig 4E). Immunofluorescent staining for Scx confirmed a 
normal restricted staining pattern prior to injury with presence of scattered intramuscular 
Scx+ cells present post-cardiotoxin consistent with regions of new HO (Fig 4F). 
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DISCUSSION 
 These findings indicate that scleraxis-lineage restricted cells have the capacity to 
form HO in the settings of trauma and with hyperactive BMP receptor activity. Recent 
studies have identified additional candidate HO including endothelial or non-endothelial 
Tie2+ cells and Glast-Cre cells (Kan and Kessler, 2014; Kan et al., 2013; Lemos et al., 
2015; Medici et al., 2010; Wosczyna et al., 2012). Using markers such as PDGFRα, Sca1, 
and S100A4, others have shown that Tie2+ and Glast-cre cells which contribute to HO 
are likely mesenchymal cells (Kan and Kessler, 2014; Kan et al., 2013; Lemos et al., 
2015; Medici et al., 2010; Wosczyna et al., 2012). Our findings confirm the co-
expression of these mesenchymal cell markers in Scx-creERT2 cells, in both trauma or 
BMP-scaffold implantation. Interestingly, while these markers are not highly enriched in 
uninjured tissue, they are expressed throughout the early anlagen and persist into regions 
of hypertrophic chondrocyte formation in both models of HO suggesting that these 
markers pointing to a conserved role for mesenchymal cells in both processes.  
 The physical source of cells contributing to HO is also of interest. Previous 
studies identified Scx-cre cells in muscle interstitium and along fascial planes (Mendias 
et al., 2012). Our data were consistent with this demonstrating restriction of both active 
scleraxis and scleraxis lineage to areas of tendon and connective tissue within the muscle. 
In the setting of trauma and BMP-induced HO, pre-injury scleraxis-lineage restricted 
cells contributing to HO may originate locally and it is possible that the differences in 
regional sources of Scx-cre cell in uninjured tissue contributes to differences in the 
prevalence of Scx-cre cells in the HO anlagen between our models. Our findings using 
the tamoxifen inducible model of caACVR1 expression (Scx-creERT2/caACVR1
fl/wt
) 
demonstrate that hyperactive BMP signaling restricted to these cells is sufficient to form 
HO consistent with the idea that these cells form a local/regional pool of prospective HO 
progenitors. 
 Interestingly using Scx-cre/caACVR1
fl/wt 
mice we found that HO was restricted to 
the tendons, with no evidence of intramuscular HO in the absence of injury. However, we 
have also found that Scx-cre cells are located intramuscularly and that intramuscular 
injury was sufficient to cause enrichment of Scx expressing cells in regions adjacent to 
pre-existing connective tissue planes. Interestingly, even when we controlled for trauma-
induced Scx-activation using conditional Scx-creERT2/caACVR1
fl/wt
 mice, injury was still 
sufficient to cause intramuscular HO in the background of caACVR1 expression. This 
suggests either these contributing cells are derived from another source, or that the injury 
stimulus causes these cells to form HO and highlights the possibility that these cells 
proliferate in response to trauma, causing an identifiable lesion.  
Our findings are just as important for what they are unable to show – the 
existence of a single progenitor cell which contributes to tHO.  Identification of a single 
progenitor cell responsible for HO has posed a challenge to researchers, and our findings 
lead us to believe that although a single scleraxis-progenitor is likely not entirely 
responsible for HO. It is possible that a broader lineage inclusive of the Scx lineage is 
responsible for HO, although identification of this broader lineage may not be realistic. 
Our findings do indicate that a subset of connective tissue cells identified by post-natal, 
pre-injury Scleraxis expression are capable of chondrogenic and osteogenic 
differentiation after local injury or with hyperactive BMP receptor activity. 
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FIGURE LEGEND 
 
Figure 1. Scleraxis-lineage cells contribute to all phases of trauma-induced heterotopic 
ossification (tHO). (A) Scleraxis lineage (Scx-cre/ROSA26
mTmG
) defines the Achilles 
Tendon (eGFP+) prior to injury; (B) Scleraxis lineage (Scx-cre/ROSA26
mTmG
) defines 
both fibroproliferative (eGFP+; white arrow) and chondroid (eGFP+; yellow arrow) tHO 
after injury; (C) Experimental set up of tamoxifen induction in Scx-creERT2/tdTomato
fl/fl 
mice with burn/tenotomy (tHO) or BMP-induced models (bHO); (D) Localization of 
adult pre-injury scleraxis-lineage restricted cells (tdTomato+) cells in the 
fibroproliferative and (tdTomato+; white arrow), chondroid (tdTomato+; yellow arrow) 
cells of cartilaginous tHO and in the endosteal cells (tdTomato+; green arrow) of late-
ossified tHO; (E) Quantification of the adult pre-injury scleraxis-lineage restricted 
fraction of in the fibroproliferative, chondroid, and endosteal cells in tHO. Scale bars 
represent 200 µm. 
 
Figure 2. Scleraxis-lineage cells defined in the uninjured adult (tdTomato+) contribute 
directly to the endochondral anlagen in both trauma-induced (tHO) and BMP-scaffold 
driven (bHO) heterotopic ossification. (A) Representative H&E demonstrating areas of 
tHO in Scx-creERT2/tdTomato
fl/fl
 mice; (B) Expression of SOX9 (green) by tdTomato+ 
cells in tHO; (C) Expression of OSX (green) by tdTomato+ cells in tHO; (D) Percent of 
Scx-creERT2 cells (tdTomato+) expressing SOX9 or OSX in tHO (5 high power fields); 
(E) Representative H&E demonstrating areas of bHO in Scx-creERT2/tdTomato
fl/fl
 mice; 
(F) Expression of SOX9 (green) by tdTomato+ cells in bHO; Expression of OSX (green) 
by tdTomato+ cells in bHO; (G) Percent of Scx-creERT2 cells (tdTomato+) expressing 
SOX9 or OSX in bHO (5 high power fields). Scale bars represent 200 µm. 
 
Figure 3. Scleraxis-lineage cells defined in the uninjured adult (Scx-
creERT2/tdTomato
fl/fl
) display mesenchymal cell markers in both trauma-induced (tHO) 
and BMP-scaffold (bHO) heterotopic ossification. (A) Scx-creERT2 cells (tdTomato+) 
express PDGFRα in tHO; (B) Scx-creERT2 cells (tdTomato+) express S100A4 in tHO; 
(C) Scx-creERT2 cells (tdTomato+) express  SCA1 in tHO; (D) Percent of Scx-creERT2 
cells (tdTomato+) which express mesenchymal markers in tHO (5 high power fields); (E) 
Scx-creERT2 cells (tdTomato+) express PDGFRα in bHO; (F) Scx-creERT2 cells 
(tdTomato+) express S100A4 in bHO; (G) Scx-creERT2 cells (tdTomato+) express  Sca1 
in bHO; (H) Percent of Scx-creERT2 cells (tdTomato+) expressing mesenchymal 
markers in bHO (5 high power fields). Scale bars represent 200 µm. 
 
Figure 4. Scleraxis lineage-restricted caACVR1 expression causes tendon and 
intramuscular HO. (A) Schematic showing spontaneous HO generation by scleraxis-
lineage cells expressing caACVR1 (Scx-cre/caACVR1
fl/wt
) and by pre-injury scleraxis-
lineage cells after cardiotoxin injury (Scx-creERT2/caACVR1
fl/wt
); (B) Photograph of Scx-
cre/caACVR1
fl/wt
 mouse showing ectopic bone formation at the hindlimb; (C) Whole 
body 3D MicroCT reconstruction confirming ectopic bone formation at the hindlimbs 
Scx-cre/caACVR1
fl/wt 
mouse; (D) Axial, sagittal, and serial cross sections of microCT 
showing ectopic bone at the distal Achilles’ tendon; (E) 3D MicroCT reconstruction 
showing HO in the hamstring muscle of Scx-creERT2/caACVR1
fl/wt 
mice induced with 
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tamoxifen and later injected with cardiotoxin with serial cross sections; H&E, Alcian 
blue, and Alizarin red staining of HO after cardiotoxin injection in non-decalcified 
sections of intramuscular HO in Scx-creERT2/caACVR1
fl/wt 
mouse; (F) 
immunofluorescent staining for scleraxis in muscle of Scx-creERT2/caACVR1
fl/wt 
mice in 
the presence or absence of cardiotoxin. Scale bars represent 200 µm. 
 
Supplemental Figure 1. Injury to Scleraxis expressing tendon is sufficient to form 
heterotopic ossification. (A) Hindlimb Achilles’ tendon transection forms HO at the 
tendon transection site; Skin incision over the Achilles’ tendon does not form HO. 
Yellow arrow = tibia; orange arrow = fibula; red circle = heterotopic ossification; cm = 
calf muscle. (B) Active scleraxis expression (Scx-GFP) is present in the Achilles Tendon 
(eGFP+) prior to injury. Scale bars represent 200 µm. 
 
Supplemental Figure 2. Scleraxis is restricted to connective tissue within muscle. (A) 
Scleraxis lineage (Scx-cre/ROSA26
mTmG
) defines the intramuscular connective tissue 
(eGFP+) but not myofibrils prior to injury. (B) Active scleraxis expression (Scx-GFP) is 
present in intramuscular connective tissue (eGFP+) but not myofibrils prior to injury. 
Scale bars represent 200 µm. 
 
Supplemental Figure 3. Scleraxis-lineage cells contribute to the development of 
cartilaginous tissue in heterotopic ossification (tHO). Scleraxis lineage (Scx-
cre/ROSA26
mTmG
) defines a majority chondroid cells (eGFP+) in tHO after injury. Scale 
bars represent 200 µm. 
 
Supplemental Figure 4. Expression of tdTomato in tamoxifen induced conditional 
reporters (Scx-creERT2/tdTomato
fl/fl
) is limited areas of tendon and connective tissue. 
Scale bars represent 200 µm. 
 
Supplemental Figure 5. Expression of mesenchymal progenitor markers are limited in 
uninjured muscle and tendon. Scale bars represent 200 µm. 
 
Supplemental Figure 6. Scx-cre/caACVR1
fl/wt 
mice do not form intramuscular HO in the 
absence of injury. MicroCT demonstrating absence of HO in the hamstring or calf 
muscles of Scx-cre/caACVR1
fl/wt 
mice after 6 weeks with serial cross sections.  
 
Supplemental Figure 7. caACVR1 expression restricted to osteoblasts or myocytes does 
not result in HO. (A) Western blot confirming that Ckmm-cre
+/0
/caACVR1
fl/wt 
overexpress 
pSmad 1/5 when compared with littermate Cre(-) control; (B) Plain film radiography 
showing absence of HO in Col1.creERT/ROSA26
LacZ
/caACVR1
fl/wt
; (C) 
Immunohistochemistry showing LacZ expression indicating recombination with 
concordant pSmad 1/5/8 expression. Scale bars represent 200 µm. 
 
Supplemental Figure 8. Intramuscular scleraxis expression (Scx-GFP) is present in 
regions adjacent to connective tissue after cardiotoxin injection. Scale bars represent 200 
µm. 
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Graphical Abstract. Scleraxis lineage cells contribute to genetic and traumatic induced 
HO.  (A) Scleraxis lineage (Scx-cre/ROSA26
mTmG
) characterizes Achilles tendon. (B) Co-
expression of scleraxis lineage (Scx-creERT2/tdTomato
fl/fl
) cells with markers of 
chondrogenic and osteogenic differentiation (Osx and Sox9). (C) Gross imaging and µCT 
reconstruction of de novo HO formation in Scx-cre/caACVR1
fl/wt 
mouse. (D) Induction of 
intramuscular HO following ctx injection in Scx-creERT2/caACVR1
fl/wt 
mouse. Scale bars 
represent 200 µm. 
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METHODS 
 
Ethics Statement 
 Procedures involving animals were approved by the Institutional Animal Care and 
Use Committee of the University of Michigan (PRO0005909) or the Walter Reed Army 
Institute of Research/Naval Medical Research Center Institutional Animal Care and Use 
Committee (12-OUMD-20s).  
 
Animals 
 All animals were housed in standard conditions. All mice used for burn/tenotomy 
or BMP sponge implantation were young adult male (6-8 weeks old) C57BL/6 
background. Scx-cre/ROSA26
mTmG
, Scx-cre/ROSA26
tdT 
and Scx-creERT2/ROSA26
tdT 
mice 
were used for lineage-tracing experiments. Mice with burn/tenotomy underwent 
transection of the left hindlimb Achilles’ tendon with 30% burn using a metal block 
heated to 60C applied to the depilated dorsum for 18 seconds (Peterson et al., 2014). 
Separately, mice underwent implantation of a human r-BMP loaded collagen scaffold 
into the gastrocnemius muscle with injection of cardiotoxin (Shimono et al., 2011). A 3 
mm × 1 mm–thick collagen discs are prepared by punched out of collagen sponge sheets 
(Resorbable collagen AceSurgical) with 10 µL of recombinant human BMP-2 (1 µg/10 
µL; Sigma, St. Louis, MO). An intramuscular pocket in the calf muscles was dissected 
and one rBMP-2–collagen disc was placed into each pocket. The surgical site was then 
injected with 100 µL cardiotoxin (0.3 µg/10 µL; Sigma, St. Louis, MO). Mice were 
euthanized at the indicated timepoints.  
 
Transgenic Animals 
Transgenic mice used in this study were: Scx-cre/ROSA26
mTmG
, Scx-
cre/ROSA26
tdT 
and Scx-creERT2/ROSA26
tdT
,
 
Ckmm-cre/caAcvr1
fl/wt
, or Col1.CreERT/ 
caAcvr1
fl/wt
. Col1.CreERT/ ca-Acvr1
fl/wt 
underwent tamoxifen induction during weanling 
stage at P2 through nursing.  
 
Histology and Imaging 
 Hind limbs were fixed overnight in 10% neutral buffered formalin and 
subsequently decalcified in 19% EDTA solution for 4-6 weeks at 4C. Sections were 
embedded in paraffin or optimal cutting temperature compound (OCT; Tissue-Tek; 
Sakura Finetek, USA) and 5-7 um sections were prepared. Immunofluorescence was 
carried out using primary antibodies directed against the following: SOX9 (Santa Cruz, 
Cat No. 17341 or 20095), Osterix, pSmad 1/5 (Santa Cruz, Cat No. 12353), Sca1, 
PDGFRa, or S100A4. Late timepoint ScxGfp/Scx-creERT2/ROSA26
tdT 
sections were 
stained with anti-tdT (Abcam, Cat No. 62341). 
All fluorescently stained images were taken using a Leica Upright SP5X Confocal 
Microscope or Olympus BX-51 upright light microscope equipped with standard DAPI, 
488 nm, and TRITC cubes attached to an Olympus DP-70 high resolution digital camera. 
Each site was imaged in all channels and overlaid in DPViewer before examination in 
Adobe Photoshop. 
 
Quantification of Costaining 
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 To quantify staining/costaining, we performed counts on n=5 high powered fields 
(hpfs) chosen at random from across n=3 distinct sections. Each high powered field is 
hand counted and results are tallied from 3 separate reviewers to ensure consistency. 
Immunofluorescent staining was regarded as positive, when red/green channel signal 
overlapped with or was immediately proximal to DAPI positive staining in the blue 
channel. For costaining of tdTomato+ with one of more of the fluorescent stains 
described above, we counted only a triple positive of DAPI+, tdTomato+, and whichever 
immunofluorescent stain is being evaluated. 
 
Computed Tomography (CT) Analysis  
 Mouse hindlimbs were imaged with microCT (Siemens Inveon, using 80 kVp, 
80mA, and 1100 ms exposure). Images were reconstructed to demonstrate sites of ectopic 
bone formation.  
 
Statistical Analysis  
 Experiments were performed with n≥3 using Student’s t-test. Means and SDs 
were calculated from numerical data, as presented in the text, figures, and figure legends. 
All bar graphs are presented as means. Error bars represent 1 standard deviation (s.d.).  
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Figure 2  
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Figure 3  
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Figure 4  
 
254x190mm (300 x 300 DPI)  
Page 19 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 20 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 21 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 22 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 23 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 24 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 25 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 26 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 27 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
 
 
254x190mm (300 x 300 DPI)  
Page 28 of 28
ScholarOne Support: (434) 964-4100
Stem Cells
This article is protected by copyright. All rights reserved.
